Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2020)
[Effective from January 1, 2020]
For more details click here

ICV 2019: 96.39
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2016.5(4): 992-997
DOI: http://dx.doi.org/10.20546/ijcmas.2016.504.113


Evaluation of Anti-transglutaminase Antibodies in Iraqi Patients with Celiac Disease
Ishraq Hasan*
Department of Laboratory Clinical Sciences, College of Pharmacy, Al-Mustansiriya University, Baghdad, Iraq
*Corresponding author
Abstract:

Anti-tissue antibodies have high specificity for celiac disease but measurements are limited, a substrate that is expensive, and of limited availability and ethical acceptance. Tissue transglutaminase has recently been identified as the endomysial autoantigen in celiac disease. To examine the validity of serum tissue transglutaminase antibody levels in patients with celiac disease and to assess their sensitivity and specificity against standard serological tests. Serum IgA anti-tissue transglutaminase antibody titres (measured by ELISA), IgG anti-tissue transglutaminase antibody titres (measured by a commercial ELISAwere determined in 168 untreated patients celiac disease collected from Baghdad Teaching Hospital,Iraq. patients with untreated celiac disease were positive for IgG and IgA anti-tissue transglutaminase antibodies. A bout  eighty-two  per cent of coeliac patients were anti-tissue transglutaminase antibody negative. Twenty eight of 168 patients had high titres of anti-tissue transglutaminase antibody (percentage 17.2%). the present results demonstrated the levels of IgA anti-tissue transglutaminase antibodies in the diagnosis of celiac disease. The ELISA for IgA anti-tissue transglutaminase antibodies is quantitative and easy to perform and is a valid alternative to indirect immunofluorescence for anti-tissue antibodies in screening for suspected celiac disease that’s mean it can be used as diagnostic marker for celiac disease.


Keywords: Anti-transglutaminase Antibodies,Celiac Disease,indirect immuno-fluorescence,ELISA.
Download this article as Download

How to cite this article:

Ishraq Hasan. 2016. Evaluation of Anti-transglutaminase Antibodies in Iraqi Patients with Celiac DiseaseInt.J.Curr.Microbiol.App.Sci. 5(4): 992-997. doi: http://dx.doi.org/10.20546/ijcmas.2016.504.113